028300 — HLB Share Price
- KR₩7tn
- KR₩7tn
- KR₩68bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 12.15 | ||
Price to Tang. Book | 26.52 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 102.82 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -16.97% | ||
Return on Equity | -16.72% | ||
Operating Margin | -181.01% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 56,177.4 | 69,825.99 | 179,707.91 | 42,900.56 | 68,125.73 | n/a | n/a | 12.14% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and pipes. The Company operates its business through two segments. The Composite Material segment is mainly engaged in the construction and repair of lifeboats, the manufacture and installation of pipes. The Biomedical Device Business segment is mainly engaged in the development of biopharmaceuticals, the manufacture and sale of medical devices.
Directors
- Yang Gon Jin CHM (54)
- Yong Wung Kim OTH (62)
- Gi Hong Ahn DRC (53)
- Matthew Chang DRC (46)
- Sun Gi Doh DRC (52)
- William Hearl DRC (63)
- Bok Hwan Jeon DRC (57)
- Jeong Hwan Moon DRC (58)
- Gyu Jun Choi NID (56)
- Jin Wuk Park NID (73)
- Jae Cheol Shim NID (65)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 18th, 1985
- Public Since
- July 27th, 1996
- No. of Shareholders
- 211,713
- No. of Employees
- 91
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 131,169,066

- Address
- 10-5, SEJONG, 30068
- Web
- http://www.hlbbio.co.kr/
- Phone
- +82 234534414
- Auditors
- KPMG Samjong Accounting Corp
Upcoming Events for 028300
Q2 2025 HLB Inc Earnings Release
Similar to 028300
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 21:07 UTC, shares in HLB are trading at KR₩53,400. This share price information is delayed by 15 minutes.
Shares in HLB last closed at KR₩53,400 and the price had moved by -46.5% over the past 365 days. In terms of relative price strength the HLB share price has underperformed the FTSE Developed Asia Pacific Index by -44.98% over the past year.
The overall consensus recommendation for HLB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreHLB does not currently pay a dividend.
HLB does not currently pay a dividend.
HLB does not currently pay a dividend.
To buy shares in HLB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩53,400, shares in HLB had a market capitalisation of KR₩7tn.
Here are the trading details for HLB:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 028300
Based on an overall assessment of its quality, value and momentum HLB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in HLB is KR₩65,682. That is 23% above the last closing price of KR₩53,400.
Analysts covering HLB currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HLB. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.76%.
As of the last closing price of KR₩53,400, shares in HLB were trading -29.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The HLB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩53,400.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
HLB's management team is headed by:
- Yang Gon Jin - CHM
- Yong Wung Kim - OTH
- Gi Hong Ahn - DRC
- Matthew Chang - DRC
- Sun Gi Doh - DRC
- William Hearl - DRC
- Bok Hwan Jeon - DRC
- Jeong Hwan Moon - DRC
- Gyu Jun Choi - NID
- Jin Wuk Park - NID
- Jae Cheol Shim - NID